CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult disease.
Bast
Robert C
RC
Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. rbast@mdanderson.org
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood*; D018394:CA-125 Antigen / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009362:Neoplasm Metastasis / Q000175:diagnosis / Q000628:therapy; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000473:pathology* / Q000523:psychology / Q000628:therapy; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012107:Research Design
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen